Puma Biotechnology filed a lawsuit against AstraZeneca for patent infringement related to Tagrisso, resulting in a jury awarding $107.5 million in damages to Wyeth, but AstraZeneca's motion challenging the jury's verdict has led to a ruling that some patents are invalid, which Puma plans to appeal.